| Authors: |
Frame D; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Scappaticci GB; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Department of Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI., Braun TM; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI., Maliarik M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Sisson TH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Pipe SW; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI., Lawrence DA; Department of Cardiovascular Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Richardson PG; Division of Hematologic Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Holinstat M; Division of Pharmacology, University of Michigan Medical School, Ann Arbor, MI., Hyzy RC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Kaul DR; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Gregg KS; Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Lama VN; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Yanik GA; Blood and Marrow Transplant Program, Michigan Medicine, Ann Arbor, MI; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI. Electronic address: gyanik@med.umich.edu. |
